Replies to post #388046 on Anavex Life Sciences Corp (AVXL)

[MycroftHolmes]

Re: Upset

I’m upset.

There is so no reason to get upset. Emotion clouds analysis.

You know failing a trial is forgivable — because such is science. You can’t blame a company for a failed trial/drug. That’s what science is about.

Did the companies that fail use Precision Medicine and a 'fail early' strategy to safeguard against wasting investor dollars? Because as an investor I very much like the Anavex approach.

over and over again, such terrible communication and showmanship by the CEO

Can I ask how long you have followed this company?

I have followed Missling for many years now. I must say that, if anything, he has been too understated in comparison to other non-revenue bio-tech CEOs.

I respect and understand his anti-hype strategy but at times selling the vision becomes necessary and his tendency to under-sell is not my preference.

That is what made this presentation so startling, they finally just stated the results in clear terms. I respect that very much. I also respect them having a meeting on Monday to walk us through it.

Stock lost 60%. But the CEO (D Ingram) has extreme credibility.

That CEO has my respect but not my investment dollars for his science.

Thank you for your analysis of the slide numbers. I plan to dig deeper into them over the weekend. Best of luck in your investments.

Cheers

Mycroft

[williamssc]

Your trying too hard. Trial was and is very successful against a really tough disease. Read the 8k.

[ignatiusrielly35]

The company has essentially already stated that there were no material misstatements in the slide deck and the broad conclusions in the PR remain unchanged. All endpoints met. Being subjected to nitpicking FUD because the data has not been fully fleshed out does not render Missling ineffective. They did a fantastic job despite being faced with crushing time constraints.